MYR Group
MYRG
313.08
-11.43
-3.52%
MYR Group
US · MYRG
#2163 by market cap
Listed 1970
313.08
-11.43
-3.52%
Live - 5344 symbols - heartbeat 241s ago
· 2026-10-08 07:55
Pre-market
303.05
-3.20%
After-hours
313.08
0.00%
- Market cap
- 4.87B
- P/E (TTM)i
- 29.73
- P/Bi
- 6.46
- EPSi
- 7.53
- Div yieldi
- 0.00%
- 52W posi
- 39%
Reader sentiment
Are you bullish or bearish on MYRG?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.15, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.79% YoY
Margins
- Gross margin
- 11.59%
- Operating margin
- 4.45%
- Net margin
- 3.24%
Key ratios & quality
- Enterprise valuei
- 4.80B
- PEG ratioi
- 2.40
- Altman Z-Scorei
- 6.15
PEG uses trailing P/E against the 3-year net income growth rate (12.40%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.53B | 2.07B | 2.25B | 2.50B | 3.01B | 3.64B | 3.36B | 3.66B |
| Gross profit | 167.06M | 214.16M | 275.85M | 324.98M | 343.96M | 364.40M | 290.32M | 423.79M |
| Selling & admin expenses | 118.74M | 156.67M | 188.54M | 207.21M | 222.42M | 234.61M | 238.22M | 256.36M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 46.48M | 53.64M | 83.73M | 115.46M | 112.53M | 124.88M | 47.23M | 162.61M |
| Pretax profit | 43.07M | 50.44M | 81.39M | 116.31M | 114.20M | 125.00M | 46.49M | 161.28M |
| Tax | 11.77M | 14.23M | 22.63M | 31.30M | 30.82M | 34.01M | 16.23M | 42.87M |
| Net profit | 31.29M | 36.21M | 58.76M | 85.01M | 83.38M | 90.99M | 30.26M | 118.42M |
| Basic EPS | 2 | 2 | 4 | 5 | 5 | 5 | 2 | 8 |
| Diluted EPS | 1.87 | 2.26 | 3.48 | 4.95 | 4.91 | 5.40 | 1.83 | 7.53 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 833.62M | 900.33M | 950.40M | 973.54M | 1.00B | 1.08B |
| Gross profit | 96.90M | 103.71M | 111.89M | 111.28M | 134.44M | 142.67M |
| Selling & admin expenses | 62.52M | 63.31M | 65.92M | 64.60M | 69.42M | 74.41M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 33.19M | 39.19M | 44.76M | 45.48M | 63.80M | 67.05M |
| Pretax profit | 32.77M | 37.39M | 44.73M | 46.39M | 64.03M | 67.13M |
| Tax | 9.46M | 10.93M | 12.64M | 9.84M | 17.23M | 17.28M |
| Net profit | 23.31M | 26.47M | 32.09M | 36.55M | 46.80M | 49.85M |
| Basic EPS | 1 | 2 | 2 | 2 | 3 | 3 |
| Diluted EPS | 1.45 | 1.70 | 2.05 | 2.33 | 2.99 | 3.17 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 475.63M | 639.18M | 636.68M | 748.39M | 890.29M | 1.03B | 929.41M | 1.06B |
| Cash & ST investments | 7.51M | 12.40M | 22.67M | 82.09M | 51.04M | 24.90M | 3.46M | 150.16M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 748.76M | 1.01B | 995.86M | 1.12B | 1.40B | 1.58B | 1.49B | 1.64B |
| Total current liabilities | 283.81M | 396.81M | 443.40M | 498.60M | 666.96M | 747.20M | 663.65M | 795.28M |
| Short-term debt | 4.80M | 16.08M | 11.31M | 8.80M | 15.91M | 18.33M | 17.55M | 18.38M |
| Long-term debt | 86.11M | 157.09M | 25.04M | 3.46M | 35.48M | 29.19M | 70.02M | 54.48M |
| Total liabilities | 424,291,000.00 | 643,396,000.00 | 566,567,000.00 | 601,990,000.00 | 838,658,000.00 | 927,544,000.00 | 888,444,000.00 | 983,656,000.00 |
| Total equity | 324.46M | 364.48M | 429.29M | 519.10M | 560.20M | 651.20M | 600.36M | 660.42M |
| Retained earnings | 174.74M | 212.22M | 270.48M | 355.01M | 404.91M | 492.53M | 453.72M | 503.24M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 968.23M | 1.02B | 1.07B | 1.06B | 1.09B | 1.08B |
| Cash & ST investments | 10.90M | 22.96M | 76.21M | 150.16M | 163.19M | 137.87M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.52B | 1.59B | 1.65B | 1.64B | 1.67B | 1.67B |
| Total current liabilities | 738.75M | 766.39M | 800.92M | 795.28M | 827.68M | 770.68M |
| Short-term debt | 17.59M | 18.22M | 18.52M | 18.38M | 18.20M | 18.54M |
| Long-term debt | 82.70M | 81.62M | 67.42M | 54.48M | 4.72M | 4.72M |
| Total liabilities | 973,389,000.00 | 1,003,748,000.00 | 1,027,744,000.00 | 983,656,000.00 | 970,605,000.00 | 918,048,000.00 |
| Total equity | 548.67M | 583.23M | 617.59M | 660.42M | 702.82M | 754.42M |
| Retained earnings | 408.15M | 434.60M | 466.69M | 503.24M | 549.78M | 599.60M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 84.79M | 64.90M | 175.17M | 137.23M | 167.48M | 71.02M | 87.12M | 326.57M |
| Depreciation & amortization | 39.91M | 44.52M | 46.45M | 46.21M | 58.17M | 59.14M | 65.19M | 66.51M |
| Free cash flow | 34.09M | 7.07M | 130.81M | 84.87M | 90.43M | -13.72M | 11.18M | 232.20M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -1.04M | -- | -- | 0 | -36.98M | -2.87M | -75.00M | -75.00M |
| Ending cash balance | 7.51M | 12.40M | 22.67M | 82.09M | 51.04M | 24.90M | 3.46M | 150.16M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 83.29M | 32.86M | 95.59M | 114.83M | 84.75M | 3.33M |
| Depreciation & amortization | 16.19M | 16.35M | 16.74M | 17.24M | 17.76M | 18.01M |
| Free cash flow | 70.22M | 11.64M | 65.41M | 84.93M | 68.62M | -25.59M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -75.00M | 0 | 0 | 0 | 0 | 0 |
| Ending cash balance | 10.90M | 22.96M | 76.21M | 150.16M | 163.19M | 137.87M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.19 | 10.97 | 14.81 | 17.93 | 15.45 | 15.02 | 4.84 | 18.78 |
| ROA %i | 4.60 | 4.29 | 5.87 | 8.03 | 6.62 | 6.11 | 1.92 | 7.36 |
| ROIC %i | 8.59 | 8.69 | 11.98 | 16.82 | 14.56 | 13.82 | 4.74 | 16.44 |
| 5-year avg ROE %i | 9.04 | 8.89 | 10.18 | 12.32 | 13.87 | 14.83 | 13.61 | 14.40 |
| EBIT margin %i | 3.05 | 2.74 | 3.82 | 4.73 | 3.91 | 3.57 | 1.58 | 4.56 |
| FCF / sales %i | 2.23 | 0.34 | 5.82 | 3.40 | 3.01 | -- | 0.33 | 6.35 |
| Current ratioi | 1.68 | 1.61 | 1.44 | 1.50 | 1.33 | 1.37 | 1.40 | 1.33 |
| Quick ratioi | 1.64 | 1.58 | 1.37 | 1.41 | 1.26 | 1.31 | 1.34 | 1.26 |
| Debt / assetsi | 12.34 | 18.89 | 5.23 | 2.27 | 5.33 | 4.66 | 8.06 | 6.30 |
| LT debt / equityi | 27.13 | 47.83 | 9.50 | 3.22 | 10.47 | 8.49 | 17.06 | 12.89 |
| Interest coveragei | 12.79 | 9.10 | 18.84 | 65.65 | 33.05 | 26.31 | 8.13 | 29.56 |
| Revenue CAGR (3Y) %i | 12.98 | 21.93 | 17.00 | 17.73 | 13.25 | 17.48 | 10.41 | 6.73 |
| Net income CAGR (3Y) %i | 4.42 | 20.71 | 40.57 | 39.84 | 30.30 | 15.69 | -29.13 | 12.40 |
| FCF CAGR (3Y) %i | -- | -37.61 | -- | 35.54 | 133.85 | -- | -49.12 | 36.94 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 5.71 | 12.56 | 16.22 | 18.78 | 22.68 | 24.71 |
| ROA %i | 2.23 | 4.82 | 6.04 | 7.36 | 8.88 | 10.14 |
| ROIC %i | 5.42 | 11.26 | 13.98 | 16.44 | 19.99 | 21.62 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 1.87 | 3.57 | 4.24 | 4.56 | 5.16 | 5.64 |
| FCF / sales %i | 2.94 | 3.15 | 4.44 | 6.35 | 6.03 | 4.83 |
| Current ratioi | 1.31 | 1.33 | 1.33 | 1.33 | 1.31 | 1.40 |
| Quick ratioi | 1.26 | 1.28 | 1.31 | 1.26 | 1.25 | 1.34 |
| Debt / assetsi | 8.68 | 8.44 | 7.23 | 6.30 | 3.68 | 4.01 |
| LT debt / equityi | 20.88 | 19.84 | 16.26 | 12.89 | 6.16 | 6.44 |
| Interest coveragei | 9.16 | 16.33 | 21.35 | 29.56 | 40.35 | 61.17 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Commercial and Industrial (C&I) is the largest reported line at 51.56% of revenue, across 2 reported segments.
- Transmission and Distribution (T&D) follows at 48.44%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Commercial and Industrial (C&I)51.56%
Transmission and Distribution (T&D)48.44%
Quote time 2026-10-08 07:55:33 · For reference only, not investment advice and not tailored to your situation.